2024 Sangamo therapeutics market cap

Sangamo therapeutics market cap

Author: jiyu

August undefined, 2024

Webb14 apr. 2024 · The stock has a market capitalization of $281.21 million, a PE ratio of -1.31 and a beta of 1.08. Sangamo Therapeutics has a 52 week low of $1.35 and a 52 week high of $6.42. Sangamo Therapeutics (NASDAQ:SGMO - Get Rating) last announced its earnings results on Wednesday, February 22nd WebbMarket Cap 0.35B Stock Price 1.93 About Sangamo Therapeutics Sangamo Therapeutics is focused on translating science into genomic medicines with the potential to transform patients' lives using the company's platform technologies in genome editing, gene therapy, gene regulation, and cell therapy. Headquarters Location 7000 Marina Blvd

Sangamo Therapeutics Inc. (NASDAQ: SGMO): Forecast Weak In …

Webb11 apr. 2024 · At the end of the latest market close, Sangamo Therapeutics Inc. (SGMO) was valued at $1.63. The stock current value is $1.49. Sangamo Therapeutics Inc. had a … Webb14 apr. 2024 · Shares of NASDAQ:AEY opened at $1.12 on Friday. The company has a market cap of $15.83 million, a P/E ratio of 37.33 and a beta of 0.49. The company has a debt-to-equity ratio of 0.10, a current ... jenks public schools canvas portal

Sangamo Therapeutics Company Profile - Craft

Webb25 mars 2024 · Sangamo is, currently, trading at a market cap of around $700M, which is almost as much as its cash position. While its cash position will eventually deplete to fund operations and clinical... Webb13 apr. 2024 · With the market capitalization of Sangamo Therapeutics Inc. currently standing at about $234.79 million, investors are eagerly awaiting this quarter’s results, … Webb24 dec. 2024 · With a market capitalization of US$1.2b, Sangamo Therapeutics is a decent size, so it is probably on the radar of institutional investors. In the chart below, we can see that institutions are ... p5r easy money

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Average ...

StockNews.com Begins Coverage on ADDvantage Technologies …

Webb11 apr. 2024 · Insiders seem to have made the most of their holdings by selling US$144k worth of REGENXBIO Inc. (NASDAQ:RGNX) stock at an average sell price of US$30.01 during the past year.The company's market valuation decreased by US$92m after the stock price dropped 11% over the past week, but insiders were spared from painful losses. Webb14 apr. 2024 · The average price point forecasted by analysts for Sangamo Therapeutics Inc. (SGMO) is $10.69, which is $9.05 above the current market price. The public float for SGMO is 138.98M, and currently, short sellers hold a 13.43% ratio of that floaft. The average trading volume of SGMO on April 14, 2024 was 1.81M shares. p5r evil synthetic organismWebbIntroduction of Sangamo Therapeutics, including company profile, stock information, contact number, and company business introduction. jenks public schools child nutrition

"WebbNews Sangamo Therapeutics Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.24 Market Cap $363.92 M Shares Outstanding … " - Sangamo therapeutics market cap

Sangamo therapeutics market cap

SGMO Sangamo Therapeutics Inc. Stock Price & News - WSJ

Webb7 mars 2024 · As previously reported, Sangamo Therapeutics, Inc. (the "Company") is a party to the Open Market Sale Agreement℠, dated August 5, 2024 (the "Original Sales … Webb13 apr. 2024 · Clovis Oncology (NASDAQ:CLVSQ – Get Rating) and Oncotelic Therapeutics (OTCMKTS:OTLC – Get Rating) are both small-cap medical companies, but which is the superior business?We will contrast the ...

Did you know?

WebbIn the wake of Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) latest US$56m market cap drop, institutional owners may be forced to take severe actions Yahoo 02/25 08:26 Sangamo Therapeutics rises 5% on Q4 2024 earnings beats SA Breaking News 02/23 19:54 Sickle-cell gene therapy developer stops program, cuts half of staff Yahoo 02/23 17:36 … WebbSangamo is using groundbreaking science and novel technology to replace today’s symptomatic treatments with tomorrow’s genomic cures. We are pursuing programs …

WebbSGMO - Sangamo Therapeutics, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Draw Fullscreen Settings SGMO - Stock Price Chart SGMO [NASD] Webb3 mars 2024 · Within the last quarter, Sangamo Therapeutics (NASDAQ:SGMO) has observed the following analyst ratings: According to 4 analyst offering 12-month price targets in the last 3 months, Sangamo...

Webb31 jan. 2024 · 970,870. 8.078604. Back to SGMO Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end ... Webb13 apr. 2024 · The firm has a market capitalization of $4.42 million, a PE ratio of -0.11 and a beta of 0.01. ... Comparing Sangamo Therapeutics (NASDAQ:SGMO) & Innate Pharma (OTCMKTS:IPHYF)

Webb14 apr. 2024 · Garmin pays an annual dividend of $2.92 per share and has a dividend yield of 2.9%. Garmin pays out 57.9% of its earnings in the form of a dividend. As a group, “Search & navigation equipment ...

Webb25 feb. 2024 · It appears that the board holds about US$1.5m worth of stock. This compares to a market capitalization of US$447m. Many investors in smaller companies … p5r elderly\\u0027s meaning of lifeWebbFör 1 dag sedan · Sangamo Therapeutics (SGMO) ... RBC Capital Remains a Buy on Sangamo Biosciences (SGMO) 04/07/23-8:46AM EST TipRanks ... Sangamo down post-market as Novartis, ... p5r crowWebb13 apr. 2024 · Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) and Innate Pharma (OTCMKTS:IPHYF – Get Rating) are both small-cap medical companies, but which is the … jenks public schools calendar 2022 2023WebbIn this position, played a lead role in the strategic development and globalisation of the Animal Health business, including entry into the US market. Qualifications are a first class honors degree in Veterinary Science from Melbourne University and an MBA from the Melbourne Business School. Specialties: Biotechnology, Pharmaceuticals Business … p5r crashWebbFör 1 dag sedan · Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited... p5r find a way to the cabinWebbTop market news, company earnings, real-time market data and in-depth market analysis from Moomoo. jenks public schools community educationWebb10 mars 2024 · Item 8.01 Other Events. As previously announced on March 10, 2024, Sangamo Therapeutics, Inc. ("Sangamo") had approximately $34.4 million in deposits … p5r farewell presents